Table 3 Subgroup / Google / Rudd AG / HP / Creative Commons / BioMed Central Ltd. / Shimizu / Konkola / SPSS Inc. / /
Country
Germany / Sweden / Austria / United States / Finland / / /
Event
FDA Phase / /
Facility
Kossel Institute / Ernst Moritz Arndt University / University of Rostock / University Medicine / Helsinki University Central Hospital / University of Giessen / Justus Liebig University / Medical University of Graz / University Medical Centre Berlin / Institute of Quality Assurance Hesse / Lund University Hospital / /
vascular disease / strokes / arteriosclerosis / Ischemic stroke / large study addressing young stroke / Cerebral hemorrhage / statutory stroke / intracerebral hemorrhage / Acute Stroke Treatment criteria / transient ischemic attack / young strokes / subarachnoid hemorrhage / acute stroke / ischaemic stroke / young stroke / comprehensive prospective stroke / hypertension / disease / atherosclerosis / Brain infarctions / rare disease / largest observational young stroke / Stroke / Diabetes / Fabry's disease / Fabry disease / diabetes mellitus / brain infarction / large young stroke / thrombosis / everyday stroke / large representative stroke / /
MedicalTreatment
thrombolytic therapy / /
OperatingSystem
Microsoft Windows / /
Organization
National Institute of Health / Justus Liebig University / University of Giessen / Department of Neurology / York University / Institute of Quality Assurance Hesse / Institute of Quality Assurance Hesse of the Federal State of Hesse / Lund University / /
Person
Gerhard Jan / /
Position
Prime Minister / neurologist / author / Commissioner / representative / /
Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy